These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

628 related articles for article (PubMed ID: 9512972)

  • 41. [Allopurinol in the treatment of hyperuricemia and chronic gout].
    Benedetti A; Nardini A; Busonera G
    Clin Ter; 1968 Apr; 45(2):141-54. PubMed ID: 5736585
    [No Abstract]   [Full Text] [Related]  

  • 42. Intermittent control of hyperuricemia in the treatment of gout.
    Bull PW; Scott JT
    J Rheumatol; 1989 Sep; 16(9):1246-8. PubMed ID: 2681764
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Which uric acid value is in need of treatment?].
    Siegenthaler-Zuber G
    Schweiz Med Wochenschr; 1976 Apr; 106(14):487-91. PubMed ID: 1265467
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Uric acid-lowering effect of a combination of benzbromarone and allopurinol--studies under standardized dietary conditions].
    Löffler W; Gröbner W; Zöllner N
    Arzneimittelforschung; 1983; 33(12):1687-91. PubMed ID: 6686776
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum urate levels and gout flares: analysis from managed care data.
    Sarawate CA; Patel PA; Schumacher HR; Yang W; Brewer KK; Bakst AW
    J Clin Rheumatol; 2006 Apr; 12(2):61-5. PubMed ID: 16601538
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Familial gout and nephropathy in a young woman. Report of one case].
    Badilla A; Rojas C
    Rev Med Chil; 2001 Jun; 129(6):666-70. PubMed ID: 11510209
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Uric acid, allopurinol therapy, and mortality in patients with acute heart failure--results of the Acute HEart FAilure Database registry.
    Málek F; Ošťádal P; Pařenica J; Jarkovský J; Vítovec J; Widimský P; Linhart A; Fedorco M; Coufal Z; Miklík R; Krűger A; Vondraková D; Špinar J
    J Crit Care; 2012 Dec; 27(6):737.e11-24. PubMed ID: 22699032
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Emerging therapies in the long-term management of hyperuricaemia and gout.
    Stamp LK; O'Donnell JL; Chapman PT
    Intern Med J; 2007 Apr; 37(4):258-66. PubMed ID: 17388867
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Hypersensitivity syndrome during therapy with allopurinol in asymptomatic hyperuricemia with a fatal outcome].
    Hammer B; Link A; Wagner A; Böhm M
    Dtsch Med Wochenschr; 2001 Nov; 126(47):1331-4. PubMed ID: 11719858
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Hyperuricemia and gout--treatment].
    Gröbner W; Walter-Sack I
    Dtsch Med Wochenschr; 2002 Feb; 127(5):210-3. PubMed ID: 11821994
    [No Abstract]   [Full Text] [Related]  

  • 51. [Therapy with alllopurinol and benzbromarone, single and combined. Renal elimination of lithogenous and colloid protective substances (author's transl)].
    Mertz DP
    Med Klin; 1977 Apr; 72(15):664-8. PubMed ID: 857138
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The treatment of hyperuricemia after kidney transplantation].
    Flury W; Ruch HR; Montandon A
    Schweiz Med Wochenschr; 1977 Sep; 107(38):1339-41. PubMed ID: 335500
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Febuxostat for prevention of gout attacks.
    Pohar S; Murphy G
    Issues Emerg Health Technol; 2006 Aug; (87):1-4. PubMed ID: 16958189
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Allopurinol treatment of hyperuricemia].
    Nissen NI; Paikin H
    Nord Med; 1967 Oct; 78(41):1320-4. PubMed ID: 6054472
    [No Abstract]   [Full Text] [Related]  

  • 55. Population pharmacokinetic and pharmacodynamic analysis of pegloticase in subjects with hyperuricemia and treatment-failure gout.
    Yue CS; Huang W; Alton M; Maroli AN; Waltrip RW; Wright D; Marco MD
    J Clin Pharmacol; 2008 Jun; 48(6):708-18. PubMed ID: 18420531
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Isolated or combined drug therapy of hyperuricemia?].
    Mertz DP
    Dtsch Med Wochenschr; 1977 Jul; 102(30):1096-7. PubMed ID: 891391
    [No Abstract]   [Full Text] [Related]  

  • 57. Febuxostat: a selective xanthine oxidase inhibitor for the treatment of hyperuricemia and gout.
    Bruce SP
    Ann Pharmacother; 2006 Dec; 40(12):2187-94. PubMed ID: 17132810
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Hyperuricemia].
    Chizyński K; Rózycka M
    Pol Merkur Lekarski; 2005 Nov; 19(113):693-6. PubMed ID: 16498814
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Allpurinol in the treatment of hyperuricemia and chronic gout].
    Benedetti A; Nardini A; Busonera G
    Rev Clin Esp; 1969 Mar; 112(6):141-54. PubMed ID: 5347028
    [No Abstract]   [Full Text] [Related]  

  • 60. [Excretion and serum concentrations of allopurinol, oxipurinol and oxipurines in combined treatment with allopurinol and benzbromarone in increasing doses].
    Mertz DP; Borner K
    Med Welt; 1983 Sep; 34(36):974-9. PubMed ID: 6633222
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.